Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:27:49.302Z.
Calculation as of: 2026-10-06T15:27:49.302Z.
Quote observation: 2026-10-06T15:24:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Modular Medical, Inc.
Market Cap
$21.03M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.22M
Free Cash Flow Yield
14.64%
TTM Avg
7.57%
3Y Avg
26.94%
5Y Avg
26.94%
Market Cap
$19.54M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.72M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.20M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.73M
Free Cash Flow Yield
N/A
TTM Avg
484.89%
3Y Avg
365.86%
5Y Avg
365.86%
Market Cap
$24.23M
Free Cash Flow Yield
N/A
TTM Avg
2.30%
3Y Avg
2.29%
5Y Avg
1.98%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.03M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $21.93M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.22M | 14.64% | 7.57% | 26.94% | 26.94% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.54M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $19.72M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.20M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.73M | N/A | 484.89% | 365.86% | 365.86% |
| NextCure, Inc. (NXTC)vs › | $18.67M | N/A | 0.44% | 0.44% | 0.44% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.23M | N/A | 2.30% | 2.29% | 1.98% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.51M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
